Quality control of a medicinal larval (Lucilia sericata) debridement device based on released gelatinase activity

Lucilia sericata Meigen (Diptera: Calliphoridae) larvae are manufactured worldwide for the treatment of chronic wounds. Published research has confirmed that the primary clinical effect of the product, debridement (the degradation of non-viable wound tissue), is accomplished by a range of enzymes re...

Full description

Bibliographic Details
Main Authors: Pickles, S.F., Pritchard, David I.
Format: Article
Published: Wiley 2017
Subjects:
Online Access:https://eprints.nottingham.ac.uk/47337/
_version_ 1848797520386326528
author Pickles, S.F.
Pritchard, David I.
author_facet Pickles, S.F.
Pritchard, David I.
author_sort Pickles, S.F.
building Nottingham Research Data Repository
collection Online Access
description Lucilia sericata Meigen (Diptera: Calliphoridae) larvae are manufactured worldwide for the treatment of chronic wounds. Published research has confirmed that the primary clinical effect of the product, debridement (the degradation of non-viable wound tissue), is accomplished by a range of enzymes released by the larvae during feeding. The quality assessment of larval activity is currently achieved during production using meat-based assays, which monitor insect growth and/or the reduction in substrate mass. To support this, we have developed a complementary radial-diffusion enzymatic assay (RDEA) to produce a visual and measureable indication of the activity of larval alimentary products (LAP) collected under standardised conditions, against a gelatin substrate. Using basic laboratory equipment and reagents, the assay is rapid and suited to high-throughput. Assay reproducibility is high (SD 0.06 - 0.27, CV 0.75 - 4.31%) and the LAP collection procedure does not adversely affect larval survival (mortality < 2%). As a cost- and time-effective method, it is suited to academic or industrial use, supporting good manufacturing (or laboratory) practice (GMP and GLP) as a quality control (QC) assay.
first_indexed 2025-11-14T20:05:11Z
format Article
id nottingham-47337
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T20:05:11Z
publishDate 2017
publisher Wiley
recordtype eprints
repository_type Digital Repository
spelling nottingham-473372020-05-04T18:43:12Z https://eprints.nottingham.ac.uk/47337/ Quality control of a medicinal larval (Lucilia sericata) debridement device based on released gelatinase activity Pickles, S.F. Pritchard, David I. Lucilia sericata Meigen (Diptera: Calliphoridae) larvae are manufactured worldwide for the treatment of chronic wounds. Published research has confirmed that the primary clinical effect of the product, debridement (the degradation of non-viable wound tissue), is accomplished by a range of enzymes released by the larvae during feeding. The quality assessment of larval activity is currently achieved during production using meat-based assays, which monitor insect growth and/or the reduction in substrate mass. To support this, we have developed a complementary radial-diffusion enzymatic assay (RDEA) to produce a visual and measureable indication of the activity of larval alimentary products (LAP) collected under standardised conditions, against a gelatin substrate. Using basic laboratory equipment and reagents, the assay is rapid and suited to high-throughput. Assay reproducibility is high (SD 0.06 - 0.27, CV 0.75 - 4.31%) and the LAP collection procedure does not adversely affect larval survival (mortality < 2%). As a cost- and time-effective method, it is suited to academic or industrial use, supporting good manufacturing (or laboratory) practice (GMP and GLP) as a quality control (QC) assay. Wiley 2017-04-25 Article NonPeerReviewed Pickles, S.F. and Pritchard, David I. (2017) Quality control of a medicinal larval (Lucilia sericata) debridement device based on released gelatinase activity. Medical and Veterinary Entomology, 31 (2). pp. 200-206. ISSN 1365-2915 Lucilia sericata; Debridement; Gelatinase; Medical device; Quality control; Wound management http://onlinelibrary.wiley.com/doi/10.1111/mve.12220/abstract doi:10.1111/mve.12220 doi:10.1111/mve.12220
spellingShingle Lucilia sericata; Debridement; Gelatinase; Medical device; Quality control; Wound management
Pickles, S.F.
Pritchard, David I.
Quality control of a medicinal larval (Lucilia sericata) debridement device based on released gelatinase activity
title Quality control of a medicinal larval (Lucilia sericata) debridement device based on released gelatinase activity
title_full Quality control of a medicinal larval (Lucilia sericata) debridement device based on released gelatinase activity
title_fullStr Quality control of a medicinal larval (Lucilia sericata) debridement device based on released gelatinase activity
title_full_unstemmed Quality control of a medicinal larval (Lucilia sericata) debridement device based on released gelatinase activity
title_short Quality control of a medicinal larval (Lucilia sericata) debridement device based on released gelatinase activity
title_sort quality control of a medicinal larval (lucilia sericata) debridement device based on released gelatinase activity
topic Lucilia sericata; Debridement; Gelatinase; Medical device; Quality control; Wound management
url https://eprints.nottingham.ac.uk/47337/
https://eprints.nottingham.ac.uk/47337/
https://eprints.nottingham.ac.uk/47337/